glp-1 lawsuits news ⚠️ CHICAGO CONSUMER ALERT: The FDA has confirmed that counterfeit versions of popular weight-loss drugs—including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound)—are circulating in the U.S., and the Chicago area is Alarming rise in weight loss
Description
finalized during chart review
Todays weight-management consumer is increasingly educated, compliance-focused, and long-term results oriented
By 2022, 44% of women were overweight, and 18% were obese
Here, we highlight the mechanisms linking T2DM and PD, as well as the links between insulin resistance (IR) and PD patients risk of developing cognitive deficits
GLP-1s are not staying in their old lanesthey are taking the fast track to altering the healthcare landscape
Learn about psychological, emotional, and behavioral changes.
